# Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL

> **NCT00187161** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 68 (actual)

## Conditions studied

- Non-Hodgkin Lymphoma
- Acute Lymphoblastic Leukemia, Mature B-Cell

## Interventions

- **DRUG:** Prednison, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Doxorubicin

## Key facts

- **NCT ID:** NCT00187161
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-11
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00187161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00187161, "Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00187161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*